$2.48
Vivos Therapeutics is a medical devices business based in the US. Vivos Therapeutics shares (VVOS) are listed on the NASDAQ and all prices are listed in US Dollars. Vivos Therapeutics employs 114 staff and has a trailing 12-month revenue of around $13.4 million.
Our top picks for where to buy Vivos Therapeutics Inc stock
How to buy Vivos Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – VVOS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Vivos Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Vivos Therapeutics stock price (NASDAQ: VVOS)
Use our graph to track the performance of VVOS stocks over time.Vivos Therapeutics shares at a glance
Latest market close | $2.42 |
---|---|
52-week range | $1.91 - $48.79 |
50-day moving average | $2.31 |
200-day moving average | $5.38 |
Wall St. target price | $7.33 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-11.05 |
Is it a good time to buy Vivos Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Vivos Therapeutics price performance over time
Historical closes compared with the close of $2.42 from 2024-07-23
1 week (2024-07-18) | -5.84% |
---|---|
1 month (2024-06-25) | 12.56% |
3 months (2024-04-25) | -1.63% |
6 months (2024-01-25) | -53.15% |
1 year (2023-07-25) | 724.81% |
---|---|
2 years (2022-07-25) | 76.64% |
3 years (2021-07-23) | 3.97 |
5 years (2019-07-21) | N/A |
Vivos Therapeutics financials
Revenue TTM | $13.4 million |
---|---|
Gross profit TTM | $12.6 million |
Return on assets TTM | -69.52% |
Return on equity TTM | -413.02% |
Profit margin | -117.06% |
Book value | $0.21 |
Market Capitalization | $8.5 million |
TTM: trailing 12 months
Vivos Therapeutics share dividends
We're not expecting Vivos Therapeutics to pay a dividend over the next 12 months.
You may also wish to consider:
- HCA (HCA.US) (0.82% forward annual dividend yield)
- Gilead Sciences (GILD.US) (4.19% forward annual dividend yield)
- Medtronic (MDT.US) (3.52% forward annual dividend yield)
Have Vivos Therapeutics's shares ever split?
Vivos Therapeutics's shares were split on a 1:25 basis on 26 October 2023. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Vivos Therapeutics shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Vivos Therapeutics shares which in turn could have impacted Vivos Therapeutics's share price.
Vivos Therapeutics share price volatility
Over the last 12 months, Vivos Therapeutics's shares have ranged in value from as little as $1.91 up to $48.79. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vivos Therapeutics's is 7.706. This would suggest that Vivos Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Vivos Therapeutics's beta into context you can compare it against those of similar companies.
- Alexion Pharmaceuticals (ALXN.US): 1.2595
- HCA (HCA.US): 1.688
- Gilead Sciences (GILD.US): 0.2
- Medtronic (MDT.US): 0.831
Vivos Therapeutics overview
Vivos Therapeutics, Inc. , a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
Frequently asked questions
What percentage of Vivos Therapeutics is owned by insiders or institutions?Currently 6.254% of Vivos Therapeutics shares are held by insiders and 8.304% by institutions. How many people work for Vivos Therapeutics?
Latest data suggests 114 work at Vivos Therapeutics. When does the fiscal year end for Vivos Therapeutics?
Vivos Therapeutics's fiscal year ends in December. Where is Vivos Therapeutics based?
Vivos Therapeutics's address is: 7921 Southpark Plaza, Littleton, CO, United States, 80120 What is Vivos Therapeutics's ISIN number?
Vivos Therapeutics's international securities identification number is: US92859E1082
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question